Astrana Health, Inc. (ASTH)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ASTH
See up to 3 months of ASTH. The 7-day demo opens the 1M and 3M ranges and puts ASTH on your watchlist.
Start 7-day demoLatest ASTH insider trades
About Astrana Health, Inc. (ASTH)
Astrana Health, Inc. is an SEC registrant, filing under CIK 0001083446, classified as management consulting services. It is grouped with Industrials companies on this site.
ASTH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 40,000 | |
| Tax withholding / forfeiture | 7 | 24,210 | |
| Derivative transaction | 3 | 40,293 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ASTH insider transactions (Form 4)
4965 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 3.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Schmidt - Director | Option exercise | Common Stock | 20,000 | $5.79 | $116K | |
| David Schmidt - Director | Tax withholding / forfeiture | Common Stock | 4,269 | $27.12 | $116K | |
| David Schmidt - Director | Option exercise | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Kenneth T. Sim - Officer | Option exercise | Common Stock | 29,502 | $17.78 | $525K | |
| Kenneth T. Sim - Officer | Option exercise | Stock Option (right to buy) | 29,502 | $0.00 | - | |
 Mitchell W. Kitayama - Director | Option exercise | Common Stock | 12,000 | $18.20 | $218K | |
| Mitchell W. Kitayama - Director | Option exercise | Stock Option (right to buy) | 12,000 | $0.00 | - | |
| Matthew Mazdyasni - Director | Option exercise | Common Stock | 20,000 | $18.20 | $364K | |
| Matthew Mazdyasni - Director | Option exercise | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Linda Marsh - Director | Option exercise | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Linda Marsh - Director | Option exercise | Common Stock | 20,000 | $18.20 | $364K | |
| Linda Marsh - Director | Tax withholding / forfeiture | Common Stock | 11,033 | $32.99 | $364K | |
| Chandan Basho - Officer | Tax withholding / forfeiture | Common Stock | 1,979 footnote F1 | $27.77 | $55K | |
| ||||||
| Mitchell W. Kitayama - Director | Option exercise | Common Stock | 8,000 | $18.20 | $146K | |
| Mitchell W. Kitayama - Director | Derivative | Common Stock | 8,000 | $30.23 | $242K | |
| Mitchell W. Kitayama - Director | Derivative | Common Stock | 5,214 | $30.23 | $158K | |
| Mitchell W. Kitayama - Director | Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Chandan Basho - Officer | Tax withholding / forfeiture | Common Stock | 1,694 | $29.70 | $50K | |
| Dinesh M. Kumar - Officer | Tax withholding / forfeiture | Common Stock | 1,694 | $29.70 | $50K | |
| David Schmidt - Director | Option exercise | Common Stock | 20,000 | $18.20 | $364K | |
| David Schmidt - Director | Derivative | Common Stock | 20,000 | $27.76 | $555K | |
| David Schmidt - Director | Option exercise | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| John Chiang - Director | Option exercise | Common Stock | 20,000 | $18.20 | $364K | |
| John Chiang - Director | Tax withholding / forfeiture | Common Stock | 12,284 | $29.63 | $364K | |
| John Chiang - Director | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Dinesh M. Kumar - Officer | Tax withholding / forfeiture | Common Stock | 6,831 | $25.06 | $171K | |
| Matthew Mazdyasni - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| Linda Marsh - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| Mitchell W. Kitayama - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| Weili Dai, - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| John Chiang - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| David Schmidt - Director | Grant or award | Common Stock | 6,449 | $0.00 | - | |
| Dinesh M. Kumar - Officer | Tax withholding / forfeiture | Common Stock | 1,656 | $25.06 | $41K | |
| Chandan Basho - Officer | Tax withholding / forfeiture | Common Stock | 10,035 | $27.18 | $273K | |
| Dinesh M. Kumar - Officer | Tax withholding / forfeiture | Common Stock | 828 | $31.15 | $26K | |
| Chandan Basho - Officer | Tax withholding / forfeiture | Common Stock | 2,683 | $34.05 | $91K | |
| Chandan Basho - Officer | Tax withholding / forfeiture | Common Stock | 1,394 | $30.02 | $42K | |
| Mitchell W. Kitayama - Director | Derivative | Common Stock | 5,100 | $43.09 | $220K | |
| John Vong - Officer | Tax withholding / forfeiture | Common Stock | 134 | $43.25 | $6K | |
| Mitchell W. Kitayama - Director | Option exercise | Common Stock | 3,409 | $18.41 | $63K | |
| Mitchell W. Kitayama - Director | Tax withholding / forfeiture | Common Stock | 1,490 | $42.11 | $63K | |
| Mitchell W. Kitayama - Director | Option exercise | Stock Option (right to buy) | 3,409 | $0.00 | - | |
| John Chiang - Director | Option exercise | Common Stock | 1,515 | $18.41 | $28K | |
| John Chiang - Director | Tax withholding / forfeiture | Common Stock | 681 | $40.93 | $28K | |
| John Chiang - Director | Option exercise | Stock Option (right to buy) | 1,515 | $0.00 | - | |
| Kenneth T. Sim - Officer | Option exercise | Common Stock | 28,046 | $18.65 | $523K | |
| Kenneth T. Sim - Officer | Option exercise | Stock option (right to buy) | 28,046 | $0.00 | - | |
| John Vong - Officer | Tax withholding / forfeiture | Common Stock | 636 | $42.91 | $27K | |
| Dinesh M. Kumar - Officer | Grant or award | Common Stock | 67,238 | $0.00 | - | |
Item 7.01, 9.01
Item 1.05
Item 7.01, 9.01
Item 2.02, 7.01, 9.01
ASTH insider trading FAQ
What is the latest insider trade for ASTH?
Astrana Health, Inc. (ASTH) had 10 insider filings in the last 90 days, with the most recent on 13 October 2026. The full record for ASTH runs to 65 Form 4 filings, the earliest from 4 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ASTH stock?
No insider purchases of ASTH were filed in the last 90 days.
How many insiders are selling ASTH stock?
No insider sales of ASTH were filed in the last 90 days.
Where can I see ASTH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ASTH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Industrials companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Vong view on EDGAR
- - Brandon Sim view on EDGAR
- - Thomas S. Lam view on EDGAR
- - Chandan Basho view on EDGAR
- - John Vong view on EDGAR
- - Brandon Sim view on EDGAR
- - Chandan Basho view on EDGAR
- - Mitchell W. Kitayama view on EDGAR
- - David Schmidt view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Industrials
- Where ASTH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ASTH with a 7-day demo
- ASTH on your watchlist
- Every ASTH Form 4 filing on record
- Up to 3 months of ASTH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
